S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

NVAX Novavax Inc

9.00

0.00 (0.00%)

Pre Market

Last Updated: 20:02:06

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

12/13/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ UBS Financial Services Inc, as attorney-in-fact for Rachel K. King

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Novavax Charts.

Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Novavax Charts.

Novavax Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 14 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 14 December 2024 (5 days ago) • Edgar (US Regulatory)

Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
Saturday 14 December 2024 (5 days ago) • PR Newswire (US)

Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
Wednesday 11 December 2024 (1 week ago) • PR Newswire (US)

Form 8-K - Current report
Wednesday 4 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million
Wednesday 4 December 2024 (2 weeks ago) • PR Newswire (US)

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
Friday 15 November 2024 (1 month ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Novavax to Participate in Jefferies London Healthcare Conference
Thursday 14 November 2024 (1 month ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

More Novavax Inc News Articles

Eqty Rel4.a1 39

Union National Agro Fund...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions